Recruiting

MedDiet vs. Usual Diet

Sponsor:

University of Illinois Chicago

Code:

NCT07869355

Conditions

Dietary Assessment

Dietary and Lifestyle Behaviour Change

Dietary Behavior

Metabolic Health

Obesity

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Explore the effect of MedDiet vs. Usual Diet on Fatty Acid Profile

Explore the effect of MedDiet vs. Usual Diet on Breast Tumor Tissue

Explore the effect of MedDiet vs. Usual Diet on Lipids

Explore the effect of MedDiet vs. Usual Diet on tumor tissue expression

Study Details

Brief summary:

Explore the effect of MedDiet vs. Usual Diet on circulating and breast tumor fatty acid profiles. The investigators aim to examine impact on tumor biology in newly diagnosed participants.

Conditions

Dietary Assessment

Dietary and Lifestyle Behaviour Change

Dietary Behavior

Metabolic Health

Obesity

Study ID

NCT07869355

Start date

Nov 11, 2026

Status verified date

Nov, 2026

Completion date

Sep 1, 2028

Anticipated

Primary completion date

Sep 1, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Age ≥ 18 years;
2. Newly diagnosed stage I-III luminal breast cancer
3. Planned surgical resection at UI Health
4. Ability to speak, read, write, and understand English
5. A Mediterranean Eating Pattern for Americans (MEPA-III) score <13 indicating that they do not currently follow a MedDiet;
6. ECOG performance status of 0 or 1.

Exclusion Criteria:

1. Currently following a MedDiet, vegan diet, or dietary restrictions (e.g., religious, food intolerance/allergy) that preclude adoption of a MedDiet;
2. Lack of access to a space to safely store and reheat foods items;
3. Living in facility that provides meals;
4. Chronic CKD stage 3+ or currently receiving dialysis treatment;
5. History of GI surgery involving removal of part of the stomach or intestines;
6. Type 1 or Type 2 diabetes;
7. Autoimmune or Inflammatory disease or immunocompromised; and
8. Cachexia.

We will not exclude other neoadjuvant treatments. Adults unable to consent Individuals who are not yet adults (infants, children, teenagers) Pregnant or breastfeeding women Prisoners

Study Design

Enrollment

30 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

active comparator: Med Diet

Mediterranean Diet (MedDiet) is a dietary pattern characterized by a low intake of saturated fats and a high intake of unsaturated fats, with olive oil as the primary culinary fat (7, 8).

no intervention: Usual Diet

Dietary fat and cancer has been conducted in preclinical models of diet-induced obesity, where high-fat diets promote tumor growth

Interventions

Explore the effect of MedDiet vs. Usual Diet on Fatty Acid Profile

Fatty acid profile (chain length and degree of saturation) in circulation of blood, tumor tissue, and tumor interstitial fluid.

Explore the effect of MedDiet vs. Usual Diet on Breast Tumor Tissue

Fatty acid profile (chain length and degree of saturation) in breast tumor tissue.

Explore the effect of MedDiet vs. Usual Diet on Lipids

Lipid availability in blood, tumor tissue, and tumor interstitial fluid.

Explore the effect of MedDiet vs. Usual Diet on tumor tissue expression

Tumor tissue will explore the effect of MedDiet vs. Usual Diet on tumor proliferation (Ki67) and expression of NK and CD8 T cells and chylomicrons (Apo48 staining).

Primary outcome measure

  • Aim 1a [ Time Frame: 3 weeks ]
  • Aim 1b [ Time Frame: 3 weeks ]
  • Aim 1c [ Time Frame: 3 weeks ]
  • Aim 2a [ Time Frame: 3 weeks ]
  • Aim 2b [ Time Frame: 3 weeks ]
  • Aim 2c [ Time Frame: 3 weeks ]
  • Aim 2d [ Time Frame: 3 weeks ]
  • Aim 2e [ Time Frame: 3 weeks ]

Central Contacts and Locations

Central contacts

Lisa Marie Tussing-Humphreys, Ph.D.

312 355 5521tussing@uic.edu

Locations

University of Illinois at Chicago Campus

Recruiting

Chicago, Illinois, United States, 60612

Contacts

Meredith Russell, BS

312 355 5112mrussel3@uic.edu

More Information

Sponsor

University of Illinois Chicago

Last update posted

Nov 16, 2026

Last verified

Nov, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by University of Illinois Chicago on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.